Historical Stock Price
ADMA historical stock prices picture
ADMA Biologics (ADMA) has the following price history information. Looking back at ADMA historical stock prices for the last five trading days, on September 17, 2020, ADMA opened at $2.39, traded as high as $2.48 and as low as $2.34, and closed at $2.41. Trading volume was a total of 1.97M shares. On September 18, 2020, ADMA opened at $2.40, traded as high as $2.44 and as low as $2.35, and closed at $2.38. Trading volume was a total of 2.76M shares. On September 21, 2020, ADMA opened at $2.35, traded as high as $2.37 and as low as $2.22, and closed at $2.26. Trading volume was a total of 2.38M shares. On September 22, 2020, ADMA opened at $2.26, traded as high as $2.26 and as low as $2.14, and closed at $2.23. Trading volume was a total of 2.39M shares. On September 23, 2020, ADMA opened at $2.23, traded as high as $2.24 and as low as $2.09, and closed at $2.12. Trading volume was a total of 1.91M shares.

ADMA Historical Stock Prices By Date:

ADMA historical cagr picture

Below, we examine the compound annual growth rate — CAGR for short — of an investment into ADMA Biologics shares, starting with a $10,000 purchase of ADMA, and working forward through the historical stock price information to today.

Growth of $10,000.00
Without Dividends Reinvested

Start date: 10/17/2013
End date: 09/23/2020
Start price/share: $8.55
End price/share: $2.12
Dividends collected/share: $0.00
Total return: -75.20%
Average Annual Total Return: -18.20%
Starting investment: $10,000.00
Ending investment: $2,480.46
Years: 6.94
Date Open High Low Close Volume
09/17/2020 $2.39 $2.48 $2.34 $2.41 1.97M
09/18/2020 $2.40 $2.44 $2.35 $2.38 2.76M
09/21/2020 $2.35 $2.37 $2.22 $2.26 2.38M
09/22/2020 $2.26 $2.26 $2.14 $2.23 2.39M
09/23/2020 $2.23 $2.24 $2.09 $2.12 1.91M
ADMA Biologics is a commercial biopharmaceutical company. Co.'s products include: BIVIGAM (Immune Globulin Intravenous, Human), an Intravenous Immune Globulin (IVIG) product indicated for the treatment of Primary Humoral Immunodeficiency (PI), also known as Primary Immunodeficiency Disease; ASCENIV (Immune Globulin Intravenous, Human – slra 10% Liquid), an IVIG product indicated for the treatment of PI; and Nabi-HB (Hepatitis B Immune Globulin, Human), which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. Co.'s products and product candidates are intended to be used by physician personnel.
Date Close
09/17/2020$2.41
09/18/2020$2.38
09/21/2020$2.26
09/22/2020$2.23
09/23/2020$2.12
ADMA is categorized under the Healthcare sector; below are some other companies in the same sector:

ADMP Historical Stock Prices
ADMS Historical Stock Prices
ADPT Historical Stock Prices
ADRO Historical Stock Prices
ADUS Historical Stock Prices
ADVM Historical Stock Prices
ADXS Historical Stock Prices
AEGR Historical Stock Prices
AEMD Historical Stock Prices
AERI Historical Stock Prices

Also explore: ADMA shares outstanding history


ADMA Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2020, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.